The spinal implants market is poised for significant expansion, with a projected valuation of USD 14.3 billion by 2028, compared to USD 11.2 billion in 2023, marking a robust compound annual growth rate (CAGR) of 5.0%. This growth is fueled by a myriad of synergistic factors, including the adoption of minimally invasive surgical techniques, increasing prevalence of spinal disorders, and…

The global biopsy devices market is on a trajectory of remarkable growth, projected to reach USD 12.6 billion by 2028 from USD 6.6 billion in 2023, with a notable CAGR of 14.0% from 2023 to 2028. This substantial growth is driven by advancements in medical technology, resulting in the creation of increasingly accurate and less invasive biopsy instruments. These innovations mitigate patient…